by Stephen Manobiano | Jun 30, 2026 | Commercialization, Marketing, news, Sales
Cell biology is the largest single technology segment in the life science tools market, and “cell biology” is exactly the kind of label that flattens two very different sales motions into one generic pitch. Single-cell sequencing resolves heterogeneity inside a...
by Stephen Manobiano | Jun 29, 2026 | Founders and Business Leaders, news
Spatial transcriptomics, spatial proteomics, and mass spectrometry imaging are converging fast. Researchers can now map gene and protein expression directly inside intact tissue, something no bulk, homogenized sample could ever show them. That’s a genuine scientific...
by Stephen Manobiano | Jun 18, 2026 | Commercialization, Fractional, news
I’ve spent the last several months at life science conferences, dinners, and networking events, talking to founders, CEOs, and investors. And I keep hearing the same thing, just in different rooms. Investors are stuck with Portfolios they can’t exit. Which...
by Stephen Manobiano | Feb 13, 2026 | Commercialization, news, tradeshows
SLAS Boston is expensive. Booth space. Freight. Travel. Hotels. Sponsorships. Swag.For many life science companies, the total investment quietly creeps into six figures. The real question executives should be asking right now isn’t: “How was the show?” It’s: Did it...
by Stephen Manobiano | Nov 15, 2025 | AI, CRM best practices, HubSpot, Marketing, news, omnichannel
From Funnels to Loops: How HubSpot’s New Marketing Studio is Transforming Life Science Commercialization In biotech, the way customers discover, evaluate, and buy has changed dramatically. Traditional marketing funnels, linear, rigid, and slow to adapt, are being...
by Stephen Manobiano | Nov 11, 2025 | business development, Commercialization, Fractional, Marketing, news, Sales
In the fast-paced world of life sciences, early-stage and growing companies often face a critical gap, not in innovation, but in leadership. They have strong scientific foundations, but lack the senior commercial expertise needed to turn potential into performance....
